Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Alveolar Cleft Treatment for Children: Systematic Review and Meta-Analysis
Life · 26.01.2025 · 15 (2) · 185
DOI: 10.3390/life15020185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 26.01.2025. Verfasst von Ebtihal Ali A Alawami und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Dentistry, Vision Colleges, Riyadh 13226, Saudi Arabia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Alveolar bone reconstruction with recombinant protein has several advantages, including less surgical timing, and reduced infection. This systematic review aims to assess the efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2) as a treatment modality for children with cleft lip and palate compared to the conventional iliac crest bone grafting approach.
Methods
For current systematic review and meta-analysis, five electronic databases, namely, MEDLINE/PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, Web of Science, and ScienceDirect, were searched. The primary outcome measured in this review was bone volume and height after alveolar bone reconstruction surgery. The Risk of Bias Tool 2 assessed the risk of bias for randomized control trials and the Risk of Bias tool for non-randomized trials of interventions for non-randomized studies. By evaluating pooled meta-analysis, the mean difference was calculated. GRADE uncertainty of evidence was performed to assess the certainty of the results.
Results
Of 230 identified studies, 6 randomized and 2 non-randomized studies were included in the current review. The average bone volume was higher among the rhBMP-2 group at 61.11% ± 24.6% than the iliac crest group at 59.12% ± 18.59%. The calculated mean bone height was higher in the iliac crest group at 78.65% ± 14.38% than in the rhBMP-2 group at 67.5% ± 5.45%. The risk of bias reported in the studies was low to moderate. The result of the meta-analysis supported using rhBMP-2 in alveolar bone reconstruction; however, no significant association was found (mean difference: −1.24; confidence interval: −4.14 to 1.67).
Conclusions
The calculated meta-analysis reported no significant difference, and the quality of evidence measured was also moderate. Hence, more clinical trials are required to support using rhBMP-2 as an alternative to traditional techniques for treating cleft lip and palate.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Dentistry, Vision Colleges, Riyadh 13226, Saudi Arabia.
- Maxillofacial Surgeon, Department of Maxillofacial Surgery and Diagnostic Sciences, King Faisal Medical City, Abha 62586, Saudi Arabia.
- College of Medicine, Bisha University, Bisha 67614, Saudi Arabia.
- College of Medicine, King Saud Bin Abdulaziz University for Health and Sciences, Jeddah 22384, Saudi Arabia.
- College of Medicine, King Saud Bin Abdulaziz University for Health and Sciences, Riyadh 11481, Saudi Arabia.
- College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
ORCID-Profile: Ebtihal Ali A Alawami, Sarah A Aloqaybi, Narjes W Alshafai, Renad Abdulaziz Saleh Alsaeed
Zitieren
APA
Alawami, E. A. A., Alomari, F., Aloqaybi, S. A., Aloweiny, Q., Alswayed, L. K., Alshafai, N. W., Alhelal, R., Alfuraydi, M. M., Samandar, A. F., Alsaeed, R. A. S., & Aldulaijan, D. (2025). Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Alveolar Cleft Treatment for Children: Systematic Review and Meta-Analysis. Life, 15(2), 185. https://doi.org/10.3390/life15020185
Vancouver
Alawami EAA, Alomari F, Aloqaybi SA, Aloweiny Q, Alswayed LK, Alshafai NW, et al. Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Alveolar Cleft Treatment for Children: Systematic Review and Meta-Analysis. Life. 2025;15(2):185. doi:10.3390/life15020185
BibTeX
@article{Alawami2025,
author = {Alawami, Ebtihal Ali A and Alomari, Fouad and Aloqaybi, Sarah A and Aloweiny, Qusay and Alswayed, Lina Khalid and Alshafai, Narjes W and Alhelal, Rawan and Alfuraydi, Moayad M and Samandar, Abdulaziz Fahad and Alsaeed, Renad Abdulaziz Saleh and Aldulaijan, Danah},
title = {Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Alveolar Cleft Treatment for Children: Systematic Review and Meta-Analysis},
journal = {Life},
year = {2025},
volume = {15},
number = {2},
pages = {185},
doi = {10.3390/life15020185}
}
EUVIMED